Atıf İçin Kopyala
Soyuoz A., KARADAĞ Ö., Karaagac T., KILIÇ L., Bilgen Ş. Ş., ÖZCEBE O. İ.
EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.5, sa.1, ss.32-36, 2018 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
5
Sayı:
1
-
Basım Tarihi:
2018
-
Doi Numarası:
10.5152/eurjrheum.2017.17088
-
Dergi Adı:
EUROPEAN JOURNAL OF RHEUMATOLOGY
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.32-36
-
Anahtar Kelimeler:
Therapeutic plasma exchange, Systemic lupus erythematosus, Primary antiphospholipid syndrome, SYSTEMIC-LUPUS-ERYTHEMATOSUS, CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME, APHERESIS, DISEASES, PLASMAPHERESIS, AUTOIMMUNE, GUIDELINES
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Objective: Therapeutic plasma exchange (TPE) offers an alternative therapeutic modality for patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (APS). However, there is conflicting evidence regarding its efficacy in different sub-phenotypes. This study aimed to investigate the main clinical characteristics and outcomes of patients with different phenotypes of SLE and APS treated with TPE at a tertiary care center.